close

Mergers and Acquisitions

Date: 2012-04-02

Type of information: Company acquisition

Acquired company: Newport Laboratories (USA)

Acquiring company: Merial (France)

Amount: undisclosed

Terms:

Merial, the Animal Health division of Sanofi has acquired Newport Laboratories, a privately held company based in Worthington, Minnesota, and a leader in autogenous vaccines with a focus on swine and bovine production markets.
Newport Laboratories is the United States leading manufacturer of autogenous biologics.  Autogenous vaccines are developed and produced from a virus or bacteria strain that has been isolated from the tissue samples submitted from a particular farm, offering veterinarians and producers alternative methods to help prevent diseases in food animals.  From this established service model approach, Newport has begun its expansion into the arena of commercial vaccines with the launch in 2010 of its first commercial swine vaccine for Haemophilus parasuis (ParaSail®). Newport Laboratories’ cutting edge molecular diagnostic technology assists in identifying pathogens, and their novel manufacturing technologies are used to produce quality “PINPOINT” evidence-based - autogenous - vaccines, offering veterinarians and producers alternative methods to help prevent diseases in food animals.  Due to this specific positioning, Newport has developed a unique relationship in the U.S. with swine producers.
Merial has been a long-standing leader in vaccine technology with recombinant-vectored vaccines for large animals and pets, the first non-adjuvanted feline vaccine line, and oral rabies vaccines for wildlife. In addition, Merial developed the first therapeutic vaccine for cancer in dogs with xenogeneic plasmid DNA vaccine technology.
This acquisition will enable Merial to expand its production animal business in the U.S. and optimize Merial’s product technology with Newport’s demand realization expertise, thus providing a unique opportunity to meet the needs of U.S. swine producers.  Newport Laboratories will continue to operate from its Worthington site and maintain its high level of service to its customers.

Details:

Related:

veterinary medicine

Is general: Yes